City

Copenhagen (1)

Redwood City (1)

Condition

DNA (2)

Androgen Receptor Abnormal (1)

Atopic Dermatitis (1)

Eczema (1)

Prostate Cancer (1)

Overall Status

Completed (1)

Withdrawn (1)

Phase

phase 2 (1)

Sponsor

Studies&Me (1)

The Netherlands Cancer Institute (1)

Collaborator

Astellas Pharma Inc (1)

Biotx.ai (1)

Bispebjerg Hospital (1)

Life&Brain (1)

Stanford Health Care (1)

Intervention

dna reports (1)

enzalutamide (1)

information reports (1)

Study Documents

Intervention Type

behavioral (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

dna

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Atopic Dermatitis - Searching for Novel Biomarkers in Clinically

Withdrawn

Atopic Dermatitis
+2 more

DNA reports
Information reports

Redwood City, California
+1 more

Sep 13, 2021

Prostate Cancer, DNA, Androgen Receptor Abnormal Trial (Enzalutamide)

Completed

Prostate Cancer
+2 more

Enzalutamide

(no location specified)

Sep 28, 2017